Track topics on Twitter Track topics that are important to you
Samsung Bioepis’s Ontruzant is set to be the first biosimilar version of Roche’s Herceptin on the EU market after getting...
Original Article: CHMP OKs First EU Biosimilar Herceptin, And Another Version Of HumiraNEXT ARTICLE
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...